Clinical Trial

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

Study acronym: Syn-G
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease and RBD? Currently, Parkinson's disease is diagnosed by observing symptoms like tremors and movement problems and RBD by loss of muscle atonia during REM sleep, but by then the disease has already progressed significantly. Earlier detection could help doctors start treatment sooner.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-11; most recent amendment 2026-02-09.
Status change: Not Yet Recruiting → Recruiting 2025-11-03
Trial Details
NCT Number NCT07217054
Lead Sponsor CND Life Sciences
Conditions PARKINSON DISEASE (Disorder), Parkinson, Parkinson s Disease, Parkinson Disease
Enrollment 40 participants
Start Date 2025-11-04
Primary Completion 2028-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-11